iRhythm Technologies Shares Fall 8% Following 2024, 2025 Outlooks

Dow Jones
2025/01/14
 

By Katherine Hamilton

Shares of iRhythm Technologies declined after the company shared its preliminary revenue for 2024 and financial outlook for 2025.

IRhythm stock fell 8%, to $90.35, midday Monday. It is down 8% over the past six months.

The digital healthcare company said it expects 2024 full-year revenue to be slightly above the high end of its previous guidance, which was $587.5 million.

IRhythm expects revenue for the full year of 2025 to be $675 million to $685 million.

New account openings in the fourth quarter of 2024 hit a record for both Zio monitor and Zio AT.

 

Write to Katherine Hamilton at katherine.hamilton@wsj.com

 

(END) Dow Jones Newswires

January 13, 2025 12:51 ET (17:51 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10